The immune response to citrullinated antigens in autoimmune diseases

This publication has 21 references indexed in Scilit:

• Investigation of polymorphisms in the PADI4 gene in determining severity of inflammatory polyarthritis
  Annals of the Rheumatic Diseases, 2005
• A family based study shows no association between rheumatoid arthritis and the PADI4 gene in a white French population
  Annals of the Rheumatic Diseases, 2005
• Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis
  Nature Genetics, 2003
• cDNA cloning, gene organization and expression analysis of human peptidylarginine deiminase type I
  Biochemical Journal, 2003
• Human Peptidylarginine Deiminase Type III: Molecular Cloning and Nucleotide Sequence of the cDNA, Properties of the Recombinant Enzyme, and Immunohistochemical Localization in Human Skin
  Journal of Investigative Dermatology, 2000
• Molecular Characterization of Peptidylarginine Deiminase in HL-60 Cells Induced by Retinoic Acid and 1α,25-Dihydroxyvitamin D3
  Journal of Biological Chemistry, 1999
• Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies.
  Journal of Clinical Investigation, 1998
• The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies.
  Journal of Clinical Investigation, 1995
• Characterisation of the rat oesophagus epithelium antigens defined by the so-called ‘antikeratin antibodies’, specific for rheumatoid arthritis.
  Annals of the Rheumatic Diseases, 1993
• The cytokeratin filament-aggregating protein filaggrin is the target of the so-called "antikeratin antibodies," autoantibodies specific for rheumatoid arthritis.
  Journal of Clinical Investigation, 1993